Fort Lauderdale, Florida--(Newsfile Corp. - May 1, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a consumer-packaged goods leader and pharmaceutical distributor, is applauding the reported historic move by the U.S. Drug Enforcement Administration ("DEA") to reclassify cannabis from its list of Schedule I drugs to Schedule III, following a recommendation from the federal Health and Human Services Department ("HHS"). "This expected rescheduling would come shortly after Germ
The recent price decline of 13% in Flora Growth Corp.'s ( NASDAQ:FLGC ) stock may have disappointed insiders who bought...
Acquisition capitalizes on TruHC's strategically built German cannabis platform, including:EU-GMP processing and production licenseGDP wholesale license for import / exportEU-GMP certified customizable modules with flexibility to incorporate various production / packaging processes and which enable license extension for future in country cultivation and supply to cannabis dispensariesNarcotics license with EU-GMP certified storageEU-GMP certified laboratory for instant cannabis analysisTransacti